PFAS compliance in cosmetics has become a critical and growing legal risk for beauty and personal care companies, driven by an expanding patchwork of state bans across 14+ jurisdictions and increasingly sophisticated consumer class action litigation that companies must address proactively rather than reactively. Click here to continue reading the full version of this alert.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is